Type 1 diabetes

Editorial board member John Wilding casts a critical eye over the positive buzz surrounding the potential uses of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes treatment.

medwireNews outlines which medications have so far been tested as adjunct treatments for type 1 diabetes and summarizes the key trial data showing their benefits or otherwise.

Editorial Board member Jay Shubrook and lead author on the American Diabetes Association’s (ADA) 2017 Position Statement on diabetes and hypertension, Ian de Boer, summarize key updates to the recommendations for practitioners in the United States (11:32).

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U300 insulin glargine and insulin degludec.

Using a patient-centered care approach, the authors detail how to work in partnership with a patient to prevent hypoglycemia through evidence-based management of the disease and appropriate education.

Editorial Board member Jay Shubrook highlights an easy-to-miss form of the disease and challenges you to make the correct diagnosis.

This review provides an overview of the diagnosis and management of hypoactive sexual desire disorder, aiming to provide a practical approach to an under-recognized complication in women with diabetes.

Diabetes check-ups can be multifaceted and time-consuming. Editorial Board member and Family Physician, Jay Shubrook, presents his practical recommendations for making the most of your patient visits.

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2017's ADA Standards of Care update. 

A call to action from editorial board member Lori Berard.

Jay Shubrook explores why it is so important to include hypoglycemia assessment and management as part of your diabetes management plan.

Professor Bart Roep talks to medwireNews about the recent renaissance in the understanding of type 1 diabetes, and of his own plans for a vaccination against the disease.

Editorial Board member Jay Shubrook follows up with treatment individualization specialist David Strain on the treatment challenges presented by older adults, and the implications for tailoring hypertension therapy in this diverse population (11:08).

Editorial Board member Jay Shubrook talks to treatment individualization specialist David Strain about the treatment challenges presented by older adults, and the implications for tailoring hypertension therapy in this diverse population (11:40)

Editorial Board member Jay Shubrook and Advisory Board member Robert Chilton get together once more to discuss best practice tips for identifying and treating hypertension in patients with pre-existing diabetes (12:17).